全文获取类型
收费全文 | 39474篇 |
免费 | 2478篇 |
国内免费 | 185篇 |
专业分类
耳鼻咽喉 | 445篇 |
儿科学 | 910篇 |
妇产科学 | 948篇 |
基础医学 | 5163篇 |
口腔科学 | 1770篇 |
临床医学 | 3030篇 |
内科学 | 10103篇 |
皮肤病学 | 977篇 |
神经病学 | 3089篇 |
特种医学 | 988篇 |
外科学 | 6161篇 |
综合类 | 258篇 |
一般理论 | 8篇 |
预防医学 | 2987篇 |
眼科学 | 671篇 |
药学 | 2159篇 |
中国医学 | 163篇 |
肿瘤学 | 2307篇 |
出版年
2023年 | 269篇 |
2022年 | 596篇 |
2021年 | 1265篇 |
2020年 | 654篇 |
2019年 | 1220篇 |
2018年 | 1457篇 |
2017年 | 896篇 |
2016年 | 934篇 |
2015年 | 1127篇 |
2014年 | 1573篇 |
2013年 | 1945篇 |
2012年 | 2989篇 |
2011年 | 3023篇 |
2010年 | 1833篇 |
2009年 | 1561篇 |
2008年 | 2448篇 |
2007年 | 2567篇 |
2006年 | 2319篇 |
2005年 | 2116篇 |
2004年 | 1921篇 |
2003年 | 1797篇 |
2002年 | 1639篇 |
2001年 | 498篇 |
2000年 | 439篇 |
1999年 | 500篇 |
1998年 | 308篇 |
1997年 | 269篇 |
1996年 | 237篇 |
1995年 | 214篇 |
1994年 | 189篇 |
1993年 | 168篇 |
1992年 | 297篇 |
1991年 | 256篇 |
1990年 | 223篇 |
1989年 | 233篇 |
1988年 | 209篇 |
1987年 | 178篇 |
1986年 | 175篇 |
1985年 | 188篇 |
1984年 | 144篇 |
1983年 | 130篇 |
1982年 | 95篇 |
1981年 | 100篇 |
1980年 | 74篇 |
1979年 | 90篇 |
1978年 | 83篇 |
1976年 | 62篇 |
1975年 | 71篇 |
1974年 | 61篇 |
1973年 | 72篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
Paula Cristina Galati Paula Garcia Chiarello Belinda Pinto Simões 《Nutrition and cancer》2016,68(1):86-93
Changes in resting energy expenditure (REE) of cancer patients vary depending on type of tumor, treatment time point and kind of treatment. Little is known about REE of acute leukemia adult patients after treatment, especially with results related to body weight or fat free mass (FFM). This study aimed to assess changes in REE of acute leukemia adult patients before and after the first remission induction. Evaluation of REE was performed by indirect calorimetry and predicted REE was calculated by Harris-Benedict equation. Weight and height were measured and compared to a control group of healthy individuals. FFM was assessed by bioelectrical impedance for adjusting REE values. We evaluated 18 patients and 26 healthy individuals. At diagnosis, patients presented REE, REE/weight, and REE/FFM higher than the controls. Reductions of REE, REE/weight, and REE/FFM were also observed in patients after the first cycle of chemotherapy. The predicted REE for the patients group showed significant lower value compared with measured REE. Before the first cycle of chemotherapy REE was increased but undergoes a reduction after treatment, reaching values similar to the controls. For predictive Harris-Benedict equation, stress factors should be added to avoid underestimation of REE before and after chemotherapy. 相似文献
5.
6.
7.
Luis J García-Flórez Guillermo Gómez-álvarez Ana M Frunza Luis Barneo-Serra Manuel F Fresno-Forcelledo 《World journal of gastrointestinal surgery》2015,7(9):196-202
AIM: To establish the association between lymph node involvement and the response to neoadjuvant therapy in locally advanced rectal cancer.METHODS: Data of 130 patients with mid and low locally advanced rectal adenocarcinoma treated with neoadjuvant chemoradiation followed by radical surgery over a 5-year period were reviewed. Tumor staging was done by endorectal ultrasound and/or magnetic resonance imaging. Tumor response to neoadjuvant therapy was determined by T-downstaging and tumor regression grading (TRG). Pathologic complete response (pCR) is defined as the absence of tumor cells in the surgical specimen (ypT0N0). The varying degrees TRG were classified according to Mandard’s scoring system. The evaluation of the response is based on the comparison between previous clinico-radiological staging and the results of pathological evaluation. χ2 and Spearman’s correlation tests were used for the comparison of variables.RESULTS: Pathologic complete response (pCR, ypT0N0, TRG1) was observed in 19 cases (14.6%), and other 18 (13.8%) had only very few residual malignant cells in the rectal wall (TRG2). T-downstaging was found in 63 (48.5%). Mean lymph node retrieval was 9.4 (range 0-38). In 37 cases (28.5%) more than 12 nodes were identified in the surgical specimen. Preoperative lymph node involvement was seen in 77 patients (59.2%), 71 N1 and 6 N2. Postoperative lymph node involvement was observed in 41 patients (31.5%), 29 N1 and 12 N2, while the remaining 89 were N0 (68.5%). In relation to ypT stage, we found nodal involvement of 9.4% in ypT0-1, 22.2% in ypT2 and 43.7% in ypT3-4. Of the 37 patients considered “responders” to neoadjuvant therapy (TRG1 and 2), there were only 4 N+ (10.8%) and the remainder N0 (89.2%). In the “non responders” group (TRG 3, 4 and 5), 37 cases were N+ (39.8%) and 56 (60.2%) were N0 (P < 0.001).CONCLUSION: Response to neoadjuvant chemoradiation in rectal cancer is associated with lymph node involvement. 相似文献
8.
9.
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation 总被引:2,自引:0,他引:2
Rolf N. Barth Christina A. Janus Christine A. Lillesand Nancy A. Radke John D. Pirsch Bryan N. Becker Luis A. Fernandez L. Thomas Chin Yolanda T. Becker Jon S. Odorico Anthony M. D''Alessandro Hans W. Sollinger Stuart J. Knechtle 《Transplant international》2006,19(11):885-892
Campath-1H (alemtuzumab) induction was used for renal transplantation in combination with sirolimus as immunosuppression. We previously reported a high (28%) rate of early rejection with this regimen, and now report 3-year outcomes. Twenty-nine patients were recipients of either deceased donor or non-HLA (Human Leukocyte Antigen) identical living donor primary renal allografts. Clinical parameters including infection, malignancy, kidney function, and kidney histology were followed prospectively for 3 years. Three-year cumulative graft and patient survival were 96% and 100%, respectively. Twenty patients were maintained on steroid-free immunosuppressive regimens, and 15 patients were maintained on monotherapy for immunosuppression (12 on sirolimus). No serious infectious complications were observed and two patients developed basal cell skin cancer. The 3-year results of our initial pilot study demonstrate good graft (96%) and patient (100%) outcomes. Campath-1H induction has yielded a high proportion of patients maintained on immunosuppressive monotherapy (57%) without serious infectious- and no malignancy-related complications. The reported regimen yielded novel insights into both Campath-1H and sirolimus therapy in renal transplantation. Because of the higher incidence of early rejection, we recommend a modified strategy of immunosuppression including a brief course of a calcineurin inhibitor. 相似文献
10.